Beam Therapeutics (BEAM)

Beam Therapeutics (BEAM) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• BEAM last traded at $26.11, -4.11% on the day.
• Beam Therapeutics: market cap $2.81B, P/E -31.7, revenue $156.03M over the last four quarters, next earnings 2026-11-03.
• Over the past year BEAM returned 9.71%; year to date -5.81%.

Updated 2026-11-02 19:25 UTC